It's the first COVID antiviral treatment approved to treat kids younger than 12.
The U.S. Food and Drug Administration on Monday approved Remdesivir to treat the virus in patients as young as 28 days old.It was previously approved for patients 12 years of age and older.That’s important because there is still no vaccine for children under 5.
In order to receive Remdesivir, infected kids must either already be hospitalized or deemed at high risk for developing severe COVID.Copyright 2022 CNN Newsource. All rights reserved.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Lire la suite »
Coronavirus: FDA approves first COVID-19 treatment for children younger than 12The FDA said Monday it expanded the approval of Veklury to include pediatric patients in certain circumstances.
Lire la suite »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Lire la suite »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Lire la suite »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Lire la suite »
COVID antiviral approved for young kids but vaccine still not availableNearly 1,700 parents and doctors across the country have filed a Citizen Petition calling on the FDA to approve a COVID vaccine for kids under 5. The petition comes on the same day the FDA announced the approval of the antiviral drug remdesivir to treat COVID patients as young as 28 days and weighing about 7 pounds.
Lire la suite »